The potential value of cerebral protection devices beyond indication of TAVI
Speakers
Dr. Lansky is a Professor of Medicine in the section of Cardiology at the Yale School of Medicine, and is a...
Dr. Lansky is a Professor of Medicine in the section of Cardiology at the Yale School of Medicine, and is a practicing cardiologist at Yale-New Haven Hospital in New Haven, CT. She has dedicated her career to leading clinical and angiographic evaluations of more than 500 clinical trials in a broad range of ischemic cardiovascular therapeutic areas, including pharmacologic and interventional device trials, many of which are landmark trials in the field and/or leading to FDA approval in the United States. She has served as the principal investigator on numerous national and international imaging studies, devices, DES, and neuroprotection trials. Dr. Lansky has authored and coauthored over 500 academic peer-reviewed manuscripts in the fields of interventional cardiology, angiography, and women’s cardiovascular health. She chaired the American Heart Association Statement on Interventions in Women and most recently the Academic Research Consortium defining Neurologic Endpoints in clinical cardiovascular trials.
Start a conversation